Latest Insider Transactions at Exelixis, Inc. (EXEL)
This section provides a real-time view of insider transactions for Exelixis, Inc. (EXEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EXELIXIS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EXELIXIS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
27,860
+4.4%
|
$390,040
$14.74 P/Share
|
|
Feb 28
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Open market or private sale
|
Direct |
82,490
-19.01%
|
$1,402,330
$17.5 P/Share
|
|
Feb 28
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Exercise of conversion of derivative security
|
Direct |
82,490
+15.97%
|
$1,154,860
$14.74 P/Share
|
|
Feb 27
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Open market or private sale
|
Direct |
10
-0.0%
|
$170
$17.5 P/Share
|
|
Feb 27
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Exercise of conversion of derivative security
|
Direct |
10
+0.0%
|
$140
$14.74 P/Share
|
|
Feb 21
2023
|
Alan M Garber Director |
SELL
Open market or private sale
|
Direct |
40,000
-56.01%
|
$680,000
$17.49 P/Share
|
|
Feb 21
2023
|
Alan M Garber Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+35.9%
|
$240,000
$6.3 P/Share
|
|
Feb 15
2023
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
1,556
-0.61%
|
$28,008
$18.08 P/Share
|
|
Feb 15
2023
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,522
-3.38%
|
$207,396
$18.08 P/Share
|
|
Feb 15
2023
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,929
-0.33%
|
$34,722
$18.08 P/Share
|
|
Feb 15
2023
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,278
-1.04%
|
$95,004
$18.08 P/Share
|
|
Feb 15
2023
|
Vicki L Goodman EVP, Prod Dev & Med Aff &CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,299
-7.14%
|
$311,382
$18.08 P/Share
|
|
Feb 15
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
1,529
-0.43%
|
$27,522
$18.08 P/Share
|
|
Feb 09
2023
|
Carl B Feldbaum Director |
SELL
Open market or private sale
|
Direct |
40,000
-68.14%
|
$680,000
$17.78 P/Share
|
|
Feb 09
2023
|
Carl B Feldbaum Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+40.53%
|
$240,000
$6.3 P/Share
|
|
Feb 06
2023
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
25,000
-8.95%
|
$425,000
$17.37 P/Share
|
|
Feb 06
2023
|
Patrick J. Haley EVP, Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+8.21%
|
$100,000
$4.2 P/Share
|
|
Jan 30
2023
|
Michael Morrissey President and CEO |
BUY
Bona fide gift
|
Indirect |
37,994
+2.76%
|
-
|
|
Jan 30
2023
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Direct |
37,994
-10.03%
|
-
|
|
Jan 24
2023
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
62,006
-14.07%
|
$1,054,102
$17.36 P/Share
|
|
Jan 24
2023
|
Michael Morrissey President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+18.5%
|
$400,000
$4.2 P/Share
|
|
Jan 05
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+22.08%
|
-
|
|
Dec 15
2022
|
Peter Lamb EVP, Scientific Strategy & CSO |
SELL
Open market or private sale
|
Direct |
20,000
-4.64%
|
$300,000
$15.88 P/Share
|
|
Dec 15
2022
|
Peter Lamb EVP, Scientific Strategy & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+4.44%
|
$80,000
$4.2 P/Share
|
|
Dec 07
2022
|
Michael Morrissey President and CEO |
BUY
Bona fide gift
|
Indirect |
106,010
+7.53%
|
-
|
|
Dec 07
2022
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Direct |
106,010
-23.73%
|
-
|
|
Nov 29
2022
|
George Poste Director |
SELL
Open market or private sale
|
Direct |
40,000
-17.15%
|
$640,000
$16.68 P/Share
|
|
Nov 29
2022
|
George Poste Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+14.64%
|
$240,000
$6.3 P/Share
|
|
Nov 15
2022
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,074
-1.56%
|
$129,184
$16.71 P/Share
|
|
Nov 15
2022
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,304
-4.96%
|
$372,864
$16.71 P/Share
|
|
Nov 15
2022
|
Peter Lamb EVP, Scientific Strategy & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,177
-1.72%
|
$114,832
$16.71 P/Share
|
|
Nov 15
2022
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,177
-1.22%
|
$114,832
$16.71 P/Share
|
|
Nov 15
2022
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
7,177
-2.74%
|
$114,832
$16.71 P/Share
|
|
Sep 12
2022
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
40,000
-13.26%
|
$680,000
$17.94 P/Share
|
|
Sep 12
2022
|
Patrick J. Haley EVP, Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+11.71%
|
$240,000
$6.21 P/Share
|
|
Aug 11
2022
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
152,867
-22.79%
|
$2,904,473
$19.23 P/Share
|
|
Aug 11
2022
|
Christopher J. Senner EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
225,000
+25.11%
|
$1,350,000
$6.21 P/Share
|
|
Aug 03
2022
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
7,177
-2.67%
|
$150,717
$21.49 P/Share
|
|
Aug 03
2022
|
Patrick J. Haley EVP, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
28,950
+9.72%
|
-
|
|
Aug 03
2022
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,177
-1.14%
|
$150,717
$21.49 P/Share
|
|
Aug 03
2022
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
28,950
+4.39%
|
-
|
|
Aug 03
2022
|
Peter Lamb EVP, Scientific Strategy & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,177
-1.69%
|
$150,717
$21.49 P/Share
|
|
Aug 03
2022
|
Peter Lamb EVP, Scientific Strategy & CSO |
BUY
Grant, award, or other acquisition
|
Direct |
28,950
+6.37%
|
-
|
|
Aug 03
2022
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,074
-1.78%
|
$169,554
$21.49 P/Share
|
|
Aug 03
2022
|
Christopher J. Senner EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
32,567
+6.69%
|
-
|
|
Aug 03
2022
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,304
-4.72%
|
$489,384
$21.49 P/Share
|
|
Aug 03
2022
|
Michael Morrissey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
94,002
+16.01%
|
-
|
|
May 27
2022
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
18,812
-7.27%
|
$338,616
$18.21 P/Share
|
|
May 26
2022
|
Carl B Feldbaum Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,180
+35.25%
|
-
|
|
May 26
2022
|
Maria C Freire Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,575
+24.69%
|
-
|